Drug Trial Radar · NCT06830863
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Aug 25, 2025
Primary completion
Jul 15, 2027
Study completion Sep 15, 2027
Sponsor
- Lead sponsor
- Azitra Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Prosoft Clinical
- First posted
- Feb 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized clinical trial is to learn if topical treatment with ATR04-484 can treat skin rash in patients undergoing EGFR inhibitor (EGFRi) therapy. The primary goal of the study is to determine safety and tolerability of ATR04-484, and the secondary goal of the study is to assess efficacy signals of ATR04-484. Researchers will compare treatment of ATR04-484 to its vehicle. Participants will: * Apply ATR04-484 or vehicle daily for 28 days * Visit the clinic periodically for evaluation and sample collection
Conditions
- EGFR Inhibitor-associated Rash
Interventions
ATR04-484Drug
ATR04-484 is a recombinant live biotherapeutic product (rLBP) containing the engineered S. epidermidis strain SE484 in an ointment formulation for topical use
VehicleDrug
Topically applied vehicle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerabilityTime frame: 57 days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Genesis Cancer and Blood Institute
Hot Springs, Arkansas · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Recruiting
NYU Langone
New York, New York · Recruiting
The Ohio State University
Gahanna, Ohio · Recruiting
MD Anderson
Houston, Texas · Recruiting
Inova Schar Cancer
Fairfax, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.